The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hövelmeyer, N.
Right arrow Articles by Waisman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hövelmeyer, N.
Right arrow Articles by Waisman, A.
The Journal of Immunology, 2005, 175: 5875-5884.
Copyright © 2005 by The American Association of Immunologists

Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis1

Nadine Hövelmeyer2,*,{dagger}, Zhenyue Hao2,3,*, Ksanthi Kranidioti{ddagger}, George Kassiotis4,{ddagger}, Thorsten Buch*, Friederike Frommer*,{dagger}, Lennart von Hoch*, Dana Kramer§, Liliana Minichiello§, George Kollias{ddagger}, Hans Lassmann and Ari Waisman5,*,{dagger}

* Laboratory for Molecular Immunology, Institute for Genetics, University of Cologne, Cologne, Germany; {dagger} I. Medical Department, Johannes Gutenberg-University, Mainz, Germany; {ddagger} Institute for Immunology, Biomedical Sciences Research Center "Al. Fleming," Vari, Greece; § European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo-Rome, Italy; and Brain Research Institute, University of Vienna, Vienna, Austria


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
In experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, immunization with myelin Ags leads to demyelination and paralysis. To investigate which molecules are crucial for the pathogenesis of EAE, we specifically assessed the roles of the death receptors Fas and TNF-R1. Mice lacking Fas expression in oligodendrocytes (ODCs) were generated and crossed to TNF-R1-deficient mice. To achieve specific deletion of a loxP-flanked fas allele in ODCs, we generated a new insertion transgene, expressing the Cre recombinase specifically in ODCs. Fas inactivation alone as well as the complete absence of TNF-R1 protected mice partially from EAE induced by the immunization with myelin ODC glycoprotein. The double-deficient mice, however, showed almost no clinical signs of EAE after immunization. Histological analysis revealed that demyelination was suppressed in CNS tissue and that lymphocyte infiltration was notably reduced. We conclude that the death receptors Fas and TNF-R1 are major initiators of ODC apoptosis in EAE. Although only moderate reduction of lymphocyte infiltration into CNS tissue was observed, the absence of these receptors appears to confer protection from demyelination and development of clinical disease.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Multiple sclerosis (MS)6 is a human autoimmune disease characterized by accumulation of lymphocytes and macrophages in the CNS (1) leading to demyelination, destruction of axons (2) and paralysis. Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated disease that is used as a model for the study of MS. In EAE, cells secreting Th1 cytokines predominate and mediate inflammatory damage while cells secreting Th2 cytokines have been associated with remission and recovery from disease (for review, see Ref.3). Immunization with myelin Ags or adoptive transfer of encephalitogenic CD4+ T cells (4) can induce EAE. T cells infiltrating into the CNS mediate an inflammatory process, resulting in demyelination and death of resident ODCs (5).

Considerable evidence has identified an important role for the apoptosis mediating ligand/receptor pairs Fas ligand (FasL)/Fas and TNF {alpha} (TNF-{alpha})/TNF-R1 in EAE. These molecules are members of the TNF and TNF-R superfamilies, respectively (6). Triggering of Fas and TNF-R1 activates overlapping signal transduction pathways including Fas-associated death domain protein and caspase-8, leading to the induction of target cell apoptosis (7).

In EAE experiments, mice mutant for TNF-{alpha} (8) or FasL (gld mice) showed a significant delay in disease onset and a remarkable reduction in demyelination (9, 10, 11). Adoptive transfer of FasL-deficient encephalitogenic T cells to wild-type (wt) mice resulted in partial reduction of EAE severity compared with the transfer of wt encephalitogenic T cells, proving that FasL expression by T lymphocytes is important for EAE pathogenesis (9, 12).

Similarly, mice deficient for the receptors Fas or TNF-R1 were shown to be partially resistant to EAE induction by immunization with myelin Ags (12, 13, 14). Adoptive transfer of myelin ODC glycoprotein (MOG)-specific wt T cells into mice harboring a natural mutation in the fas gene (lpr mice) (11) or a mutation in the tnf-r1 gene (15) showed that the presence of Fas and TNF-R1 on non-T cells is required for full development of EAE. Hence, encephalitogenic T cells activating TNF-R1 and Fas signal transduction are crucial for EAE pathogenesis.

To conclusively investigate the role of Fas in ODC destruction during the course of EAE, we generated a mouse strain, MOGi-cre/fasfl/fl, that lacks Fas expression exclusively in ODCs by the use of homologous (16) and Cre-mediated recombination (17), expressing the Cre recombinase under the control of the ODC-specific MOG promoter. The ODC-specific deletion of a loxP-flanked fas allele resulted in significant protection of the mutant mice from the induction of EAE. To investigate whether the remaining disease is mediated by TNF-R1, we analyzed mice lacking additionally the tnf-r1 gene. The mice deficient for TNF-R1 and Fas expression in ODCs were almost completely resistant to EAE induction. ODC demyelination and apoptosis was virtually absent, although a degree of lymphocyte infiltration into the CNS persisted. Thus, we show that apoptosis via Fas expressed on ODC is an important mechanism for EAE induction.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Generation of MOGi-cre mice

The open reading frame of Cre was introduced into the first exon of the mog gene followed by the polyadenylation signal of the human growth hormone. The neomycin resistance (neo) and thymidine kinase genes were used as positive and negative selection markers, respectively. C57BL/6-derived embryonic stem (ES) cells (18) were transfected with the targeting vector according to standard protocols (19). ES cells carrying the insertion were injected into CB20 blastocysts to generate the MOGi-cre mouse strain. Intercrossing of this mouse with a mouse strain carrying a loxP-flanked exon 9 of the fas gene (20) resulted in offspring harboring ODC-specific Fas deletion. To delete both Fas and TNF-R1 receptors, ODC-specific Fas-deficient mice were further bred to TNF-R1-deficient mice that were kindly provided by Dr. K. Pfeffer (21).

Western blotting

Myelin was prepared from spinal cord or brain as described previously (22). Equal amounts of myelin were loaded on a 15% SDS-polyacrylamide gel and transferred to a Protran BA 83 nitrocellulose membrane (Schleicher & Schuell BioScience). Blots were incubated with rabbit antiserum against the Ig-like extracellular domain of mouse MOG (1/1000) or anti-cyclic nucleotide phosphodiesterase (CNPase) mAb (1/3000) (Chemicon) for 2 h, followed by corresponding secondary peroxidase-conjugated anti-IgG (mouse and rabbit) (Amersham Biosciences) and developed according to the ECL protocol (Amersham).

Flow cytometry

Ab conjugates specific to the following Ags were purchased from BD Pharmingen: B220-cychrome; CD4-FITC; CD8-PE; CD90.2-PE; and TCR{alpha}{beta}-PE. Cells from lymphoid organs were stained with the Ab conjugates for flow cytometric analysis on a FACSCalibur (BD Biosciences). The data were analyzed using CellQuest software (BD Biosciences).

Induction and clinical evaluation of EAE

EAE was induced in 8- to 12-wk-old mice by injecting 50 µg of MOG p35–55 peptide (Neosystem; Ref.23) supplemented with 8 mg/ml heat-inactivated Mycobacterium tuberculosis (H37Ra strain; Difco Laboratories) in CFA (Difco Laboratories) on day 0 in the tail base. 200 ng of Bordetella pertussis toxin (List Biologicals) were administered i.p. on the day of immunization and 2 days later. Mice were monitored daily for clinical signs of EAE, graded on a scale from 0 to 5 as follows: 0 = clinically normal; 0.5 = limp tail or isolated weakness of gait; 1 = loss of tail tonicity; 2 = hind leg paralysis; 3 = hind and front leg paralysis; 4 = total hind and front leg paralysis and partial body paralysis; 5 = moribund or dead animals. Moribund animals were sacrificed.

Immunofluorescence

To assess the specificity of the Cre recombinase activity in the MOGi-cre strain, these mice were crossed to the indicator mice ROSA26-LacZ (24) or to the Z/EG mouse strain (25).

For cryosectioning, perfused whole brains of 44-day-old MOGi-cre/Z/EG mice were sectioned at 30 µm. Sections were washed three times in 0.1 M phosphate buffer, pH 7.4, for 15 min before two washings in TBS (50 mM Tris (pH 7.4), 150 mM NaCl) for 15 min. After blocking for 1 h at room temperature in blocking solution (10% normal horse serum, 0.3% carrageenin, 0.5% Triton X-100 in TBS), sections were incubated with primary Abs in 1% normal horse serum, 0.3% carrageenin, 0.5% Triton X-100 in TBS for 48 h at 4°C. Sections were washed three times for 10 min each in TBS and subsequently incubated with secondary Abs in TBS overnight at 4°C. After a washing with TBS for 10, 15, and 30 min, sections were placed on slides and allowed to dry before mounting with Vectashield mounting medium with 4',6'-diamidino-2-phenylindole.

Abs used include: primary Abs against CNPase (monoclonal, 1/100; Chemicon), S100 (polyclonal, 1:200; Sigma-Aldrich), and neuron-specific nuclear protein (NeuN; monoclonal, 1/100; Chemicon); fluorescent secondary Abs: Alexa Fluor 594 goat anti-mouse IgG (1/1000; Molecular Probes); and Texas Red AffiniPure goat anti-rabbit IgG (1/200; Jackson ImmunoResearch).

Sections were analyzed using a Leica NTS confocal microscope (FITC channel to detect native enhanced green fluorescent protein (EGFP) signal and tetramethylrhodamine isothiocyanate channel to detect immunofluorescence).

Cytokine measurement and cellular proliferation assays

To analyze the primary T cell response to the MOG peptide, inguinal and popliteal lymph nodes (LN) were harvested from mice 10–12 days after immunization with MOG peptide-CFA (as described above, but without the pertussis toxin injection). A single-cell suspension was prepared, and 2.5 x 104 lymphocytes were incubated with 2 x 105 irradiated wt splenocytes in the presence of MOG p35–55 for 72 h. Cell proliferation was assessed in triplicate cultures by adding 0.5 µCi/well [3H]thymidine (DuPont). After 18 h, cells were harvested with a Harvester 96 (Tomtec), and [3H]thymidine incorporation was determined using a Matrix 9600 direct beta counter (Packard BioScience). Cytokines were measured by ELISA as described previously (26).

Neuropathological analysis

Experimental mice were perfused with PBS-heparin followed by 4% paraformaldehyde (in PBS, pH 7.4). Paraffin-embedded sections from brains and spinal cords were stained with HE, with Luxol fast blue, or with Bielschowsky’s silver stain. Immunohistochemistry was performed as previously described (27). Primary Abs against the following targets were used: T lymphocytes (anti-CD3 from Serotec and anti-CD90 from BD Pharmingen); macrophages (anti-Mac-1 and anti-Mac-3; BD Pharmingen) and ODC (anti-CNPase and SMI-91; Sternberger Monoclonals, Lutherville, MD). The extent of inflammation was quantified by counting the perivascular inflammatory infiltrates in 10 randomly selected sections of thoracic, cervical, and lumbar spinal cord. The size of demyelinated lesions were determined by overlaying the spinal cord sections with a morphometric grid and counting the area of demyelination in relation to the total area of the spinal cord.

Apoptosis was determined by morphological criteria such as nuclear condensation and nuclear fragmentation. For evaluation of ODC apoptosis, CNPase-positive ODCs were counted in six inflamed and demyelinated areas of 66 mm2, and the average number was determined. The mean values were multiplied by 15 to determine the density of apoptotic ODCs per square millimeter.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
ODCs die by apoptosis during the course of EAE

In the course of EAE, the death of ODCs was observed and reported to be responsible for demyelination and axonal death (28). The underlying mechanisms of this degeneration remain insufficiently understood and controversial (12, 28, 29, 30). Morphologically, ODCs in MS lesions were shown to exhibit cytoplasmic swelling, organelle disruption, and membrane damage (31, 32). Similarly, apoptotic cells with oligodendroglial features have been described in EAE lesions after immunization with myelin basic protein (MBP) (28, 33). To determine whether apoptosis of ODCs can also be detected in our EAE model, brain sections of C57BL/6 mice immunized with MOG p35–55 in CFA were stained for the ODC marker CNPase and analyzed for morphological hallmarks of apoptosis (Fig. 1). We could detect all consecutive stages of apoptosis, namely condensation (Fig. 1b), deformation (Fig. 1c) and fragmentation of the nuclei in CNPase-positive cells (Fig. 1d). Thus, different phases of apoptotic death were present among ODCs in the lesions of C57BL/6 mice immunized with MOG. To investigate whether Fas is directly involved in the induction of apoptosis in these cells, we decided to delete the fas gene specifically in ODCs using Cre-mediated recombination and investigated EAE pathology in these mice.



View larger version (127K):
[in this window]
[in a new window]
  		FIGURE 1. Apoptosis of oligodendrocytes during EAE. a, Area of normal spinal cord gray matter with numerous ODCs (brown cells) and with normal cell nuclei. b–d, Apoptotic ODCs (brown cells, arrows) in areas of demyelination in MOG-EAE, showing nuclear shrinkage and chromatin condensation (b and c) and nuclear fragmentation (d). Immunohistochemistry for CNPase as a marker for ODCs and myelin (brown); the cell nuclei are stained with hematoxylin (blue). x800.

 
ODC-specific fas deletion

We therefore generated a mouse strain in which the Cre recombinase is expressed specifically in ODCs. Because expression of MOG was shown to be tightly restricted to ODCs in contrast to other myelin proteins, like phospholipoprotein and MBP (34, 35), we inserted the Cre open reading frame into the mog gene of C57BL/6-derived ES cells via homologous recombination (Fig. 2b, clone 2F5).



View larger version (35K):
[in this window]
[in a new window]
  		FIGURE 2. Generation of mice with Cre activity in ODCs. a, Scheme of the targeting strategy in which the coding region of the Cre recombinase replaced the first exon of the MOG gene. b, Southern blot analysis of DNA isolated from ES cells. Clone 2F5 that originated from C57BL/6 ES cells (Bruce-4) was used to generate chimeric mice by injection into blastocysts. c, Myelin was extracted from wt, two MOGi-cre/+, or MOGi-cre/MOGi-cre (namely, MOG knockout) mice. Myelin was separated by PAGE, and Western blot analysis was performed with either anti-MOG or anti-CNPase Abs, as indicated. d, Genomic DNA was prepared from different organs of MOGi-cre mice with or without heterozygous loxP-flanked fas allele. Upper bands, Nondeleted fasfl or wt alleles; lower bands, the product of the recombined fas gene.

 
Insertion of the Cre recombinase gene under the MOG promoter results in inactivation of the mog gene. As a result, the generated MOGi-cre mice are heterozygously deficient for the mog gene. Because EAE is induced by immunization with MOG peptide and mediated by MOG-specific T cells, different endogenous expression levels of MOG could theoretically alter the development of the autoimmune disease. We therefore tested whether heterogeneity of the mog gene in the MOGi-cre mice influences the expression levels of the MOG protein by Western blot analysis using CNS homogenate. We found that the amount of MOG from the brain expressed in heterozygous MOGi-cre mice was comparable with that in wt controls (Fig. 2c). As expected, homozygous MOGi-cre mice lacked MOG expression completely (Fig. 2c).

The MOGi-cre mouse strain was intercrossed with the fasfl/fl strain in which exon 9 of the fas gene is flanked by loxP sites (20). Because specificity and efficiency of Cre-mediated recombination vary between loxP-flanked target genes, we analyzed the Cre-mediated recombination from DNA of various organs from the MOGi-cre/fasfl/+ mice by PCR. A 240-bp product corresponding to the deletion of exon 9 was observed solely in DNA taken from brain, thus confirming CNS-specific recombination in this mouse strain (Fig. 2d).

To test the specificity of Cre-mediated recombination, we crossed the MOGi-cre mouse strain to the Z/EG reporter strain (25), in which upon Cre-recombination expression of EGFP is achieved. Brain sections from young MOGi-cre/Z/EG mice were analyzed for EGFP fluorescence to establish where Cre-mediated recombination occurred. EGFP signal was detected in cells and fiber bundles of the white matter resembling the expected distribution of ODCs (Fig. 3). To rule out the possibility of recombination occurring in neurons, brain sections were stained with NeuN (that reacts with most neuronal cell types throughout the nervous system), and confocal analysis revealed no colocalization of the two signals (Fig. 3, a–c). In contrast, the ODC-specific marker CNPase overlapped with the EGFP signal in fiber bundles and ODC cell somas as shown in Fig. 3, d–i. In addition, glial fibrillary acidic protein, a marker to identify astrocytes, did not colocalize with EGFP-positive cells (data not shown).



View larger version (93K):
[in this window]
[in a new window]
  		FIGURE 3. Cre-mediated recombination in brain of MOGi-cre mice crossed to a Z/EG reporter mouse. Brain sections of young MOGi-cre/Z/EG mice were immunostained with NeuN (a–c), CNPase (d–i), and S100 (j) Abs. Arrows in d–f indicate fiber bundles. Arrows in g–i highlight an example of ODC cell soma double-positive for EGFP and CNPase. cc, Corpus callosum; CA1, hippocampal region; IGL, internal granule layer of cerebellum; BS, brain stem; cp, caudate putamen.

 
Moreover, recombination is occurring in mature ODCs and not in precursors as revealed by S100 immunostainings of MOGi-cre/Z/EG brain sections (Fig. 3j). The S100 protein is expressed in oligodendroglial progenitors committed to differentiate into OL lineage. In the adult, S100 expression is down-regulated in mature ODCs that have established contacts with their axonal targets (36). Furthermore, the MOGi-cre-expressing mouse strain was crossed to the reporter strain ROSA26 (24), in which {beta}-galactosidase is expressed after Cre-mediated excision of a transcriptional stop cassette. Brain sections from MOGi-cre/ROSA26 mice were analyzed for the expression of {beta}-galactosidase using 5-bromo-4-chloro-3-indolyl {beta}-D-galactoside staining, to determine where in the CNS Cre-mediated recombination occurred. Blue-stained cells were found primarily in the white matter of the brain, resembling the expected distribution of ODCs (data not shown). To rule out Cre activity within lymphoid organs, spleen, thymus, and lymph node cells were stained with fluorodeoxyglucose, a substance that is rendered fluorescent by {beta}-galactosidase, and analyzed by FACS. In this assay, we did not detect Cre activity in lymphoid organs (data not shown).

Thus, in contrast to the previously published MBP-Cre mice (37), the MOGi-cre mouse does not exhibit Cre-mediated recombination activity in any tested cell type other than mature ODCs.

Normal T cell immunity in MOGi-cre/fasfl/fl mice

The immune system of fas gene mutant (lpr) mice and FasL mutant (gld) mice suffers from abnormal development and homeostasis of T and B cells. This leads to lymphoproliferative disease and accumulation of T cells expressing the B220 (CD45R) marker (38, 39). To confirm that the immune system in the MOGi-cre/fasfl/fl mice develops normally, we stained for the expression of B220 on the surface of LN T cells. In contrast to lpr mice, exhibiting the previously described population of B220 expressing T cells (Fig. 4a) (38), the fraction of TCR{alpha}{beta}+B220+ cells in LNs of the MOGi-cre/fasfl/fl was unaltered compared with wt mice (Fig. 4a). Also in the thymus we found a normal distribution of CD4/CD8 thymocytes in the different mutant mice (Fig. 4a). Together, these results demonstrate that the MOGi-cre/fasfl/fl mice do not exhibit defects in T cell development and T cell homeostasis.



View larger version (48K):
[in this window]
[in a new window]
  		FIGURE 4. Normal T cell immunity in MOGi-cre/fasfl/fl mice. a, Thymic and lymph node cells from wt, fasfl/fl, MOGi-cre/fasfl/fl, and MRLlpr/lpr mice were stained with Abs directed to CD4 and CD8 (thymus) or to B (B220) and T cells (TCR{alpha}{beta}) (lymph nodes) and analyzed by flow cytometry. b, Lymph node cells from the indicated mice were prepared 10 days after immunization with MOG p35–55 in CFA. The cells were incubated with the MOG peptide before the assessment of proliferation. Supernatants taken from the LN cell cultures were used to determine the presence of IL-2 and IFN-{gamma} by ELISA.

 
The development of EAE depends on pathogenic Th1 type T cells (40), secreting IL-2 and IFN-{gamma}. The levels of these cytokines were shown to correlate with disease severity (41). To exclude defects in T cell polarization toward the Th1 type and cytokine secretion, we tested activation and cytokine secretion of T cells from MOGi-cre/fasfl/fl and fasfl/fl control mice after immunization with MOG. Ten days after immunization, LN cells were reactivated in vitro with MOG p35–55, and the proliferative response as well as cytokine secretion was analyzed. No significant differences in the proliferative response of LN cells taken from MOGi-cre/fasfl/fl or fasfl/fl mice were detected (Fig. 4b). Furthermore, there was no difference in the amount of IL-2 and IFN-{gamma} secreted from wt- and mutant-derived LN cells (Fig. 4b).

Thus, absence of Fas in ODCs did not affect MOG-specific T cell response in the periphery. It also did not influence the ability of T cells to differentiate into IFN-{gamma} secreting Th1 cells after immunization and restimulation with MOG p35–55.

Absence of Fas in ODCs leads to partial EAE resistance

To measure EAE susceptibility, we immunized MOGi-cre/fasfl/fl and fasfl/fl control mice with the encephalitogenic MOG p35–55 (23). The mice lacking Fas expression on ODCs show a significant delay of disease onset and attenuation of disease severity in the fas-deficient mice in comparison with control animals (Fig. 5a and Table I). In contrast, the mice lacking Fas expression on ODCs do not show a decrease in disease incidence compared with control mice (Table I). Because the heterozygous MOGi-cre mice express equal amounts of the MOG protein compared with wt mice in the CNS, it was unlikely that heterozygosity of the MOG locus could influence disease severity. To further rule out possible effects of Cre expression in ODCs on the course of the disease, the EAE experiment was repeated with heterozygous MOGi-cre/+ mice as a third control group (Fig. 5b). These mice were as susceptible to EAE as the different control mice used in this study. (Fig. 5b and Table I). This result confirms that the milder disease observed in MOGi-cre/fasfl/fl mice is in fact due to the lack of Fas expression in ODCs and not to mog heterozygosity or the Cre expression.



View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 5. Mice lacking Fas on ODCs are partially resistant to EAE induction. Mice were immunized with the MOG p35–55 in CFA and followed for clinical signs of disease (a and b). All mice were sacrificed at day 23 and perfused, and the spinal cord was used for further analysis. c, Neuropathology of EAE in mice with and without Fas expression in ODCs. CNS sections were stained with H & E to quantify inflammation or with Luxol fast blue to determine the extent of demyelination. Shown is the average of leukocytes in square millimeters and the percentage of demyelination for the brains of mice shown in a.

 

View this table:
[in this window]
[in a new window]
  		Table I. Summary of EAE experiments in mice with Fas deletion and control littermates

 
Decreased inflammation and demyelination in EAE in the absence of Fas on ODC

Histological analysis was performed to assess whether the reduction of clinical disease severity correlates with reduced demyelination and/or inflammation. Twenty-four days after EAE induction, brains and spinal cords from MOGi-cre/fasfl/fl and fasfl/fl control mice were analyzed histologically. Luxol fast blue staining showed a reduction of demyelination by almost 70% in the MOGi-cre/fasfl/fl mice compared with controls (Fig. 5c). In addition, we found that mice lacking Fas specifically in ODCs showed reduced histological signs of CNS inflammation such as perivascular and parenchymal tissue infiltration by T lymphocytes and macrophages visualized by H&E staining (Fig. 5c). Compared with control mice, the infiltrated area of analyzed CNS sections from MOGi-cre/fasfl/fl mice was reduced by one-third. A similar reduction was detected for both demyelination and inflammation (data not shown). These results indicate that in addition to the direct damage of the myelin, ODC apoptosis in EAE further increases the inflammatory infiltration and thus propagates CNS pathology in EAE.

Mice lacking Fas expression by ODCs and TNF-R1 are protected against the induction of EAE

Apart from Fas-FasL, TNF-R1 was reported to play a role in the induction of ODC apoptosis in the course of EAE (42, 43, 44). It was shown that passive EAE could be induced in wt mice by adoptive transfer of TNF-R1–/– T cells (15). In contrast, TNF-R1–/– mice that were adoptively transferred with wt T cells were resistant to EAE induction (15), indicating that TNF-R1 expression by resident cells in the CNS and TNF-{alpha} secreted by the invading T lymphocytes and macrophages are critical for the development of disease. To investigate whether the residual ODC apoptosis we detected in MOGi-cre/fasfl/fl mice during EAE is mediated by activation of TNF-R1, we crossed the MOGi-cre/fasfl/fl mice to TNF-R1 deficient mice.

Further, we determined whether the additional deletion of TNF-R1 has an impact on T cell development and immunity. We observed normal B and T cell distribution among the lymphocytes in the LNs of the MOGi-cre/fasfl/fl TNF-R1–/– mice. In addition, the double-deficient mice did not exhibit the population of T cells expressing the B220 marker found in lpr mice (Fig. 6a). To assess the role of TNF-{alpha} and FasL-mediated apoptosis of ODCs during EAE, we induced EAE in the MOGi-cre/fasfl/fl TNF-R1–/– mice by immunization with MOG p35–35. In mice lacking Fas on ODCs, TNF-R1, or both receptors, the disease onset was delayed (Fig. 6b and Table II). The mice with a single mutation in either Fas or TNF-R1 showed clinical signs of EAE, although much more mildly than wt mice (Fig. 6b and results summarized in Table II). However, mice deficient for the expression of both receptors are almost completely resistant to EAE induction (Fig. 6b). Thus, we conclude that the remaining disease observed in lpr mice or mice with deletion of Fas in ODCs in EAE is a result of TNF-R1 expression in resident CNS cells and that Fas and TNF-R1 are the pivotal mediators in ODC apoptosis in EAE.



View larger version (43K):
[in this window]
[in a new window]
  		FIGURE 6. EAE resistance in mice deficient for Fas and TNF-R1. a, No apparent immune defect in T cell development of mice lacking TNF-R1. Lymph node cells from the indicated mice were stained for the T cell marker CD90 and B cell marker B220. b, Groups of mice with the indicated mutations were immunized as described in Fig. 4, and clinical disease was followed by daily observation. c, All mice were sacrificed at day 26 and evaluation was performed for inflammation and demyelination as described in Fig. 4. In addition, we assessed the extent of ODC apoptosis in the CNS of these mice.

 

View this table:
[in this window]
[in a new window]
  		Table II. EAE induced in mice with Fas and TNF-RI deletion and control littermates

 
Reduced inflammation and lack of demyelination in the CNS of double-deficient mice

To investigate whether the absence of the proapoptotic receptors Fas and TNF-R1 on the surface of ODCs will indeed lead to the reduction of ODC apoptosis during EAE, we immunized the different strains with MOG p33–35 and analyzed nuclear condensation and fragmentation to identify apoptosis. Mice deficient for Fas in ODCs have a mild reduction of ODC apoptosis after EAE induction, whereas mice deficient for TNF-R1 show only 25% of the ODC apoptosis observed in wt mice (Fig. 6c). Mice lacking both TNF-R1 expression and Fas expression in ODCs had only occasional apoptotic ODCs in the spinal cord after immunization, indicating that Fas and TNF-R1 are the major receptors mediating ODC apoptosis during EAE.

Although the clinical course of the disease was similar for mice with Fas deficiency on ODC and TNF-R1–/– mice, respectively, the latter showed a greater reduction in demyelination in comparison to wt mice (Figs. 6c and 7h compared with Fig. 7, b and e). The double-deficient mice exhibit even less demyelination, as summarized in Fig. 6c (see also Fig. 7k). We found that demyelination mirrors to a large extent the findings of ODC apoptosis in the CNS of the different mice.



View larger version (99K):
[in this window]
[in a new window]
  		FIGURE 7. Mice deficient in Fas on ODCs and for TNF-R1 retain a moderate level of inflammation in the CNS with no signs of EAE. CNS from the immunized mice was stained with H & E (left column) to detect inflammation, with Luxol fast blue (middle column) to visualize myelin, or with Bielschowsky silver (right column) to determine the extent of axonal injury. Shown are representative slides for mice of each group: wt (a–c); MOGi-cre/fasfl/fl (d–f); fasfl/fl (g–i); TNF-R1–/– orMOGi-cre/fasfl/fl, TNF-R1–/– (j–l). x100.

 
Because we showed that in MOG p35–55 immunized MOGi-cre/fasfl/fl mice the reduction in demyelination is accompanied by reduced inflammatory infiltrates (Fig. 5), we questioned whether infiltrating lymphocytes in the CNS are further reduced or absent in the double-deficient mice. Histological analysis of CNS tissue from the experimental mice was performed. Mice deficient for TNF-R1 or for Fas in ODCs exhibited reduced levels of inflammation in comparison with wt mice (Fig. 6c, and exemplified in Fig. 7). In contrast to the difference in the level of demyelination in the two single-mutant mouse strains, they show comparable levels of inflammation, in both cases reduced compared with results in wt mice. Although the double-deficient mice have a merely moderate reduction of inflammation in the CNS compared with the single mutant mice, they exhibit only a very mild clinical course of EAE.

Further, we analyzed the extent of neuronal damage in the CNS of the different mice. Spinal cords of the mice taken 24 days after EAE induction were analyzed for axonal injury by Bielschowsky silver staining. We demonstrate that MOGi-cre/fasfl/fl TNF-R1–/– mice show minimal axonal injury (compare Fig. 7l with Fig. 7c).

Together, these results demonstrate that in the MOGi-cre/fasfl/fl TNF-R1–/– model lymphocytes can invade and populate the CNS, but the lack of apoptosis-mediating receptors on the surface of ODCs is conducive to cell survival and diminished EAE severity.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Previous reports demonstrated a role for the death receptors Fas and TNF-R1 and their ligands in the induction and development of EAE. The disruption of Fas-FasL interaction in gld, as well as lpr mice, partially protected them from EAE pathogenesis (10, 45). To further investigate the role of Fas-FasL interactions in EAE pathogenesis, we generated mice deficient for Fas expression specifically in ODC and tested their susceptibility to ODC apoptosis, demyelination, brain inflammation, and clinical disease after induction of EAE. In addition, we combined the ODC-specific Fas mutation with a mutation in the TNF-R1 gene. We assumed that these two signaling pathways together are responsible for ODC apoptosis and further speculated that this process is critical for disease development. Because the use of gld and lpr mice for the analysis of EAE is hampered by defects in the immune system, leading to lymphoproliferative disease (38), we analyzed actively induced EAE in mice deficient for Fas specifically in ODCs and mice deficient for TNF-R1. As expected, we found no evidence for alterations of the immune system neither in MOGi-cre/fasfl/fl mice nor in TNF-R1–/– mice. Similarly, MOGi-cre/fasfl/fl TNF-R1–/– double-deficient mice did not display alterations in the immune system. T cell proliferation or IL-2 and IFN-{gamma} secretion by T cells after activation with MOG p35–55 were also normal. These data confirm that the MOGi-cre/fasfl/fl and the TNF-R1/Fas double-deficientmice are suitable mouse models to analyze EAE development and pathogenesis.

Upon induction of EAE with MOG p35–55, we found decreased disease severity as well as delayed onset of EAE in ODC-specific Fas-deficient mice. Thus, absence of Fas on ODCs can partially protect mice from EAE. This result compliments published data that showed that absence of Fas (lpr mice) on non-bone marrow-derived cells protects mice from EAE (9). Thus, we have now shown that Fas-FasL interaction between cells of the immune system (presumably MOG-specific T cells) and ODCs plays an important role in the induction of ODC death. Consequently, we strengthened the published data indicating that ODCs are critical target cells of the autoimmune response in the primary step of EAE, because preventing their apoptosis reduces the clinical course of the disease. Although a contribution of other cell types expressing Fas (i.e., neurons and astrocytes) cannot be ruled out completely, our data are supported by the finding that the transfer of wt encephalitogenic T cells into FasL-deficient mice resulted in EAE, proving a main role of T cell-ODC interaction, involving Fas-FasL (12).

Although we have shown that death of ODCs via Fas-FasL interaction is necessary for full induction of EAE, the mice lacking Fas on ODC suffered from a milder form of the disease. In accordance, Sabelko-Downes et al. (9) have previously published that mice lacking Fas expression are still susceptible to EAE, albeit to a lower degree than wt mice. This milder disease therefore had to be mediated by alternative factors. Similar to Fas, TNF-R1 was shown to promote apoptosis of ODCs during EAE (14). Thus, we reasoned that TNF-TNF-R1 interaction is responsible for mediating the remaining disease observed in mice lacking Fas expression on ODCs. We demonstrate that mice with double deficiency of Fas in ODCs and TNF-R1 are almost completely resistant to EAE induction.

The mice lacking these two major apoptosis-mediating receptors, Fas and TNF-R1, still exhibited moderate levels of inflammation in the CNS. In contrast, we found very little damage in the CNS in those mice. Together, these data are consistent with the fact that damage to ODCs is crucial for clinical signs of EAE and that inflammation of the CNS will not indefinitely result in EAE pathogenesis, because mice deficient for Fas on ODCs are protected from apoptosis by the invading lymphocytes although the latter are able to enter the CNS.

Fas expression was detected on ODCs of MS patients, where highest expression was seen at the edges of the lesion (46). It was shown that during the inflammatory reaction in the CNS of MS patients, Fas expression is up-regulated in CNS cells in a process involving IFN-{gamma} (47, 48, 49). FasL expression in the human brain was reported for microglia, indicating a role of these cells in disease development. In addition, in the course of MS, apoptotic death of ODCs in acute plaques was shown, although the vast majority of apoptotic cells were found to be T cells (50, 51).


   Acknowledgments
 
We thank Anke Leinhaas, Angela Egert, and Claudia Uthoff-Hachenberg for excellent technical assistance. We thank Dr. Ulrich Kalinke, Dr. Jack Zapulla, Dr. Stefan Brocke, Christine Tertilt, and Iana Parvanova, as well as Andrew Croxford and Carsten Merkwirth for critically reading the manuscript. Further, we thank Alexander Pozhitkov for help with statistical analysis.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by European Commonwealth Grant TAGAPO QLG1-CT-1999-00202 (to G.K., A.W., and K. Rajewsky), a grant from the Koerber Foundation (to K. Rajewsky), Grant 998003 from the Juvenile Diabetes Foundation (to K. Rajewsky), and by Deutsche Forschungsgemeinschaft Grant SFB 548 (to A.W.). T.B. and L.vH. were fellows of the International Graduate School of Functional Genomics and Genetics at Institute for Genetics, Cologne, Germany. Back

2 These authors contributed equally to this work. Back

3 Current address: Advanced Medical Discovery Institute, Toronto, Ontario M5G 2C1, Canada. Back

4 Current address: Division of Molecular Immunology, The National Institute for Medical Research, Mill Hill, London, United Kingdom. Back

5 Address correspondence and reprint requests to Dr. Ari Waisman, I. Medical Department, Johannes Gutenberg-University Mainz, Verfügungsgebäude, Obere Zahlbacher Strasse 63, 55131 Mainz, Germany. E-mail address: waisman{at}uni-mainz.de Back

6 Abbreviations used in this paper: MS, multiple sclerosis; EAE, experimental autoimmune encephalomyelitis; ES, embryonic stem; FasL, Fas ligand; ODC, oligodendrocyte; MOG, myelin ODC glycoprotein; LN, lymph nodes; MBP, myelin basic protein; EGFP, enhanced green fluorescent protein; CNPase, cyclic nucleotide phosphodiesterase; wt, wild type; NeuN, neuron-specific nuclear protein. Back

Received for publication December 30, 2004. Accepted for publication August 19, 2005.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Keegan, B. M., J. H. Noseworthy. 2002. Multiple sclerosis. Annu. Rev. Med. 53:285.-302. [Medline]
  2. Lassmann, H.. 2002. Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clin. Neurol. Neurosurg. 104:168.-171. [Medline]
  3. Lafaille, J. J.. 1998. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9:139.-151. [Medline]
  4. Martin, R., H. F. McFarland, D. E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.-187. [Medline]
  5. Neumann, H., I. M. Medana, J. Bauer, H. Lassmann. 2002. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25:313.-319. [Medline]
  6. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331.-367. [Medline]
  7. Thorburn, A.. 2004. Death receptor-induced cell killing. Cell Signal 16:139.-144. [Medline]
  8. Eugster, H. P., K. Frei, R. Bachmann, H. Bluethmann, H. Lassmann, A. Fontana. 1999. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29:626.-632. [Medline]
  9. Sabelko-Downes, K. A., A. H. Cross, J. H. Russell. 1999. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189:1195.-1205. [Abstract/Free Full Text]
  10. Sabelko, K. A., K. A. Kelly, M. H. Nahm, A. H. Cross, J. H. Russell. 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159:3096.-3099. [Abstract]
  11. Dittel, B. N., R. M. Merchant, C. A. Janeway, Jr. 1999. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162:6392.-6400. [Abstract/Free Full Text]
  12. Dittel, B. N.. 2000. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Arch. Immunol. Ther. Exp. (Warsz.) 48:381.-388. [Medline]
  13. Sabelko-Downes, K. A., J. H. Russell, A. H. Cross. 1999. Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. J. Neuroimmunol. 100:42.-52. [Medline]
  14. Probert, L., H. P. Eugster, K. Akassoglou, J. Bauer, K. Frei, H. Lassmann, A. Fontana. 2000. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123:(Pt 10):2005.[Abstract/Free Full Text]
  15. Gimenez, M. A., J. E. Sim, J. H. Russell. 2004. TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J. Neuroimmunol. 151:116.-125. [Medline]
  16. Capecchi, M. R.. 1989. Altering the genome by homologous recombination. Science 244:1288.-1292. [Abstract/Free Full Text]
  17. Gu, H., J. D. Marth, P. C. Orban, H. Mossmann, K. Rajewsky. 1994. Deletion of a DNA polymerase {beta} gene segment in T cells using cell type-specific gene targeting. Science 265:103.-106. [Abstract/Free Full Text]
  18. Köntgen, F., G. Suss, C. Stewart, M. Steinmetz, H. Bluethmann. 1993. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5:957.-964. [Abstract/Free Full Text]
  19. Kühn, R., F. Schwenk, M. Aguet, K. Rajewsky. 1995. Inducible gene targeting in mice. Science 269:1427.-1429. [Abstract/Free Full Text]
  20. Hao, Z., B. Hampel, H. Yagita, K. Rajewsky. 2004. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J. Exp. Med. 199:1355.-1365. [Abstract/Free Full Text]
  21. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.-467. [Medline]
  22. Norton, W. T., S. E. Poduslo. 1973. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:749.-757. [Medline]
  23. Mendel, I., N. Kerlero de Rosbo, A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V{beta} expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951.-1959. [Medline]
  24. Mao, X., Y. Fujiwara, S. H. Orkin. 1999. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. USA 96:5037.-5042. [Abstract/Free Full Text]
  25. Novak, A., C. Guo, W. Yang, A. Nagy, C. G. Lobe. 2000. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28:147.-155. [Medline]
  26. Waisman, A., P. J. Ruiz, D. L. Hirschberg, A. Gelman, J. R. Oksenberg, S. Brocke, F. Mor, I. R. Cohen, L. Steinman. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:899.-905. [Medline]
  27. Vass, K., H. Lassmann, H. Wekerle, H. M. Wisniewski. 1986. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol. (Berl.) 70:149.-160. [Medline]
  28. Pender, M. P., K. B. Nguyen, P. A. McCombe, J. F. Kerr. 1991. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104:81.-87. [Medline]
  29. Bonetti, B., J. Pohl, Y. L. Gao, C. S. Raine. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159:5733.-5741. [Abstract]
  30. Hisahara, S., H. Okano, M. Miura. 2003. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci. Res. 46:387.-397. [Medline]
  31. Prineas, J. W., E. E. Kwon, E. S. Cho, L. R. Sharer. 1984. Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann. NY Acad. Sci. 436:11.-32. [Medline]
  32. Prineas, J. W., E. E. Kwon, P. Z. Goldenberg, A. A. Ilyas, R. H. Quarles, J. A. Benjamins, T. J. Sprinkle. 1989. Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 61:489.-503. [Medline]
  33. Raine, C. S., L. B. Barnett, A. Brown, T. Behar, D. E. McFarlin. 1980. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:150.-157. [Medline]
  34. Pham-Dinh, D., M. G. Mattei, J. L. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I. H. Mather, K. Artzt, K. F. Lindahl, A. Dautigny. 1993. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90:7990.-7994. [Abstract/Free Full Text]
  35. Bruno, R., L. Sabater, M. Sospedra, X. Ferrer-Francesch, D. Escudero, E. Martinez-Caceres, R. Pujol-Borrell. 2002. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur. J. Immunol. 32:2737.-2747. [Medline]
  36. Deloulme, J. C., E. Raponi, B. J. Gentil, N. Bertacchi, A. Marks, G. Labourdette, J. Baudier. 2004. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Mol. Cell. Neurosci. 27:453.-465. [Medline]
  37. Niwa-Kawakita, M., V. Abramowski, M. Kalamarides, G. Thomas, M. Giovannini. 2000. Targeted expression of Cre recombinase to myelinating cells of the central nervous system in transgenic mice. Genesis 26:127.-129. [Medline]
  38. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.-317. [Medline]
  39. Adachi, M., S. Suematsu, T. Suda, D. Watanabe, H. Fukuyama, J. Ogasawara, T. Tanaka, N. Yoshida, S. Nagata. 1996. Enhanced and accelerated lymphoproliferation in Fasnull mice. Proc. Natl. Acad. Sci. USA 93:2131.-2136. [Abstract/Free Full Text]
  40. Powell, M. B., D. Mitchell, J. Lederman, J. Buckmeier, S. S. Zamvil, M. Graham, N. H. Ruddle, L. Steinman. 1990. Lymphotoxin and tumor necrosis factor-{alpha} production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:539.-544. [Abstract/Free Full Text]
  41. Pedotti, R., J. J. De Voss, L. Steinman, S. J. Galli. 2003. Involvement of both "allergic" and "autoimmune" mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24:479.-484. [Medline]
  42. Körner, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585.-1590. [Abstract/Free Full Text]
  43. Selmaj, K. W., C. S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339.-346. [Medline]
  44. D’Souza, S., K. Alinauskas, E. McCrea, C. Goodyer, J. P. Antel. 1995. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15:7293.-7300. [Abstract]
  45. Waldner, H., R. A. Sobel, E. Howard, V. K. Kuchroo. 1997. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:3100.-3103. [Abstract]
  46. Bonetti, B., C. S. Raine. 1997. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:74.-84. [Medline]
  47. D’Souza, S. D., B. Bonetti, V. Balasingam, N. R. Cashman, P. A. Barker, A. B. Troutt, C. S. Raine, J. P. Antel. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:2361.-2370. [Abstract/Free Full Text]
  48. Lee, S. J., T. Zhou, C. Choi, Z. Wang, E. N. Benveniste. 2000. Differential regulation and function of Fas expression on glial cells. J. Immunol. 164:1277.-1285. [Abstract/Free Full Text]
  49. Pouly, S., B. Becher, M. Blain, J. P. Antel. 2000. Interferon-{gamma} modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol. Exp. Neurol. 59:280.[Medline]
  50. Dowling, P., W. Husar, J. Menonna, H. Donnenfeld, S. Cook, M. Sidhu. 1997. Cell death and birth in multiple sclerosis brain. J. Neurol. Sci. 149:1.-11. [Medline]
  51. Raine, C. S., S. H. Stone. 1977. Animal model for multiple sclerosis. Chronic experimental allergic encephalomyelitis in inbred guinea pigs. N Y State J. Med. 77:1693.-1696. [Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
F. Frommer, T. J. A. J. Heinen, F. T. Wunderlich, N. Yogev, T. Buch, A. Roers, E. Bettelli, W. Muller, S. M. Anderton, and A. Waisman
Tolerance without Clonal Expansion: Self-Antigen-Expressing B Cells Program Self-Reactive T Cells for Future Deletion
J. Immunol., October 15, 2008; 181(8): 5748 - 5759.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Saxena, J. Bauer, T. Scheikl, J. Zappulla, M. Audebert, S. Desbois, A. Waisman, H. Lassmann, R. S. Liblau, and L. T. Mars
Cutting Edge: Multiple Sclerosis-Like Lesions Induced by Effector CD8 T Cells Recognizing a Sequestered Antigen on Oligodendrocytes
J. Immunol., August 1, 2008; 181(3): 1617 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kielian, M. Md. Syed, S. Liu, N. K. Phulwani, N. Phillips, G. Wagoner, P. D. Drew, and N. Esen
The Synthetic Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Ciglitazone Attenuates Neuroinflammation and Accelerates Encapsulation in Bacterial Brain Abscesses
J. Immunol., April 1, 2008; 180(7): 5004 - 5016.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Balabanov, K. Strand, R. Goswami, E. McMahon, W. Begolka, S. D. Miller, and B. Popko
Interferon-{gamma}-Oligodendrocyte Interactions in the Regulation of Experimental Autoimmune Encephalomyelitis
J. Neurosci., February 21, 2007; 27(8): 2013 - 2024.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
O. Aktas, T. Prozorovski, and F. Zipp
Death Ligands and Autoimmune Demyelination
Neuroscientist, August 1, 2006; 12(4): 305 - 316.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hövelmeyer, N.
Right arrow Articles by Waisman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hövelmeyer, N.
Right arrow Articles by Waisman, A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS